|
|
News Breaks | | | | September 10, 2012 | | 08:07 EDT |  | SGNT | Sagent Pharmaceuticals announces the launch of Ondansetron Injection, USP
Sagent Pharmaceuticals announced the launch of Ondansetron Injection, USP, an antiemetic, in two latex-free vial presentations. According to IMS, for the 12 months ending June 2012, the US market for Ondansetron Injection, USP approximated $49M. As with all products in Sagent's portfolio, Ondansetron features the company's PreventIV MeasuresSM packaging and labeling, designed to help reduce medication errors. | |
|
News For SGNT From The Last 14 Days Check below for free stories on SGNT the last two weeks. |
|
|
| May 6, 2013 | | 08:31 EDT |  | SGNT | Sagent Pharmaceuticals to host a conference call
Conference Call to discuss the agreement to acquire remaining 50% interest in its joint venture partner, Chengdu Kanghong Pharmaceuticals, as well as 1Q13 earnings, will be held on May 6 at 9 am. Webcast Link | | | 07:12 EDT | | SGNT | Sagent Pharmaceuticals acquires remaining 50% interest in Chinese JV
 Subscribe for More Information | | | 07:10 EDT |  | SGNT | Sagent Pharmaceuticals sees FY13 revenue $220M-$250M, consensus $238.13M
Sees FY13 net income $5M-$15M. | | | 07:08 EDT | | SGNT | Sagent Pharmaceuticals reports Q1 EPS 34c, may not compare to consensus (3c)
Subscribe for More Information | |
|
|
|
|
|
|
